Welcome
Support Centre
11 February 2012 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
Virtual Outreach: a randomised controlled trial and economic appraisal
Source of recordUK Trials
ISRCTNISRCTN54264250
Date ISRCTN assigned09/01/2002
Local reference number(s)HTA 96/02/05
Public titleVirtual Outreach: a randomised controlled trial and economic appraisal
Scientific title
AcronymN/A
Disease/condition/study domainTeleconferenced medical consultations
Study hypothesisThe project was designed to evaluate the feasibility of teleconferenced medical consultations (TMCs) at the interface between primary and secondary care. The key research objectives were:
1. To determine the views of specialists, GPs and patients about TMCs
2. To test the feasibility of TMCs
3. To determine which specialties are most suited to TMCs
4. To make plans for a randomised controlled trial of TMCs.
The key issues of interest related to the relative value of real time teleconferenced medical consultations (TMCs) as an alternative to routine outpatient referral. The study was designed to evaluate the potential of TMCs to improve patients¿ health and satisfaction, and to lead to more efficient usage of health service resources in terms of tests and investigations, procedures, operations and prescriptions. We were particularly interested to find out whether the joint consultations could reduce the number of outpatient and GP consultations following the index consultation. In addition, the study was designed to examine the educational and organisational impact of TMCs. The pilot study was carried out in order to test the feasibility of a full-scale trial. In particular we wished to find out whether we could recruit adequate numbers of patients, whether standard instruments could be used effectively to measure the key outcomes, and whether we would be able to measure the educational and organisational impact of introducing TMCs.
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration.
Countries of trialUnited Kingdom
Participants - inclusion criteriaAll patients referred by the participating general practitioners for a hospital specialist opinion in the following specialty areas: ENT medicine, general medicine (including endocrinology and rheumatology), gastroenterology, orthopaedics, neurology and urology
Participants - exclusion criteriaNot provided at time of registration.
Patient information material
Anticipated start date01/06/1998
Anticipated end date31/10/2001
Status of trialCompleted
Target number of participants2094
InterventionsVideoconference link (tele-consultation) versus routine hospital outpatients consultation
Primary outcome measure(s)The following instruments were used in the trial:
1. A patient demographic and personal details questionnaire
2. S F12 generic measure of well-being
3. Ware Specific Visit Questionnaire (SVQ) for patient satisfaction
4. Speiberger Standing State Anxiety Inventory (STAI)
5. A patient cost questionnaire
6. Duke Severity of Illness questionnaire (DUSOI) to measure the co-morbidity or burden of illness
7. Protocol specifically designed to extract data for hospital and GP records
Secondary outcome measure(s)Not provided at time of registration.
Publications1. Monograph on http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15546515
2. Study protocol on http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11835692
3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12855528
4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12076550
5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11835692
Sources of fundingNIHR Health Technology Assessment Programme - HTA (UK)
Sponsor nameDepartment of Health (UK)
Sponsor detailsQuarry House
Quarry Hill
Leeds
United Kingdom
LS2 7UE
Sponsor emailSheila.Greener@doh.gsi.gov.uk
Sponsor websitehttp://www.dh.gov.uk/en/index.htm
Contact nameProf Paul Wallace
Contact detailsDepartment of Primary Care and Population Sciences
Royal Free and University College Medical School
Rowland Hill Street
London
United Kingdom
NW3 2PF
Contact telephone+44 (0)20 7830 2339
Contact fax+44 (0)20 7830 2338
Contact emailp.wallace@pcps.ucl.ac.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN54264250
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central